QuADD - LLM Cache

April 14th, 2026· 4.7 min·
PolarisQB Demonstrates Advances in Drug Safety Prediction with Quantum-Inspired AI, Enabling Earlier Elimination of Toxic Compounds from Discovery Pipeline
PolarisQB advances drug safety prediction with quantum-inspired AI, enabling early removal
April 14th, 2026· 0.7 min·
Polaris Quantum Biotech has been selected as a 2026 winner of the Cleveland Clinic Quantum Innovation Catalyzer Program
DURHAM, NC - Polaris Quantum Biotech has been selected as a
November 22nd, 2025· 2.9 min·
PolarisQB Published A Manuscript Demonstrating The Superiority Of Quantum Computing Over AI In Drug Design
DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in
August 12th, 2025· 2.7 min·
Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform – Beta Testers Wanted
DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in
October 18th, 2024· 0.7 min·
Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets
On Tuesday, October 1, PolarisQB hosted a webinar titled "Find
September 20th, 2024· 3.8 min·
PolarisQB Joins OpenFold AI Consortium along with Congruence, Biogen, Psivant and Others
OpenFold, a leading non-profit artificial intelligence (AI) research consortium focused on
August 19th, 2024· 2 min·
Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design
PolarisQB is happy to announce the integration of Virtual Libraries and
July 31st, 2024· 0.6 min·
QuADD Webinar: Delivering Business Value with Quantum-Aided Drug Design
Quantum-Aided Drug Design (QuADD) is delivering value to our customers
May 28th, 2024· 0.6 min·
QuADD Webinar: Find Your Star Molecule
On Friday, May 17, PolarisQB hosted a group of thought
January 16th, 2024· 2 min·
PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform
POLARISqb, the first company to build quantum-enabled molecular optimization tools